08.01.2013 • News • AMRI • API manufacturing • Active Pharmaceutical Ingredients (APIs)

AMRI Promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

AMRI announced today that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice President of Pharmaceutical Development and Manufacturing.

Mr. Saffee will assume oversight for large scale manufacturing in Aurangabad, India in addition to his current responsibilities for leadership of AMRI's large scale manufacturing and GMP business in the United States in the Capital Region of New York. Additionally, Mr. Saffee will work with AMRI's Holywell, UK site to assist them in their large scale manufacturing business. Mr. Saffee will be positioned to drive synergies between the locations that will improve quality, efficiency and delivery of API's.

Before coming to AMRI, Mr. Saffee led manufacturing activities for multiple U.S.-based operations for Pfizer Global Manufacturing and Pfizer Global Human Health.

Company

Curia

Albany, NY
US

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.